Supervisor Database Search
Search for supervisors below. You can filter your search using the options and select
multiple fields by holding CTRL (Cmd on Mac) + clicking multiple options in a list.
Full NameProfessor Colm Bergin
Department:Department of GU Medicine & Infectious Diseases, St. James's Hospital
Organisation:Trinity College Dublin
- infectious disease and the immune system
Postgrad Medical Specialties
- Infectious diseases
I am a Consultant Physician in Infectious Diseases, St. James's Hospital, Dublin and Clinical Professor of Medicine at Trinity College Dublin. I am the Associate Director of the Wellcome-Health Research Board (HRB) Clinical Research Facility, St. James’s Hospital Dublin, the Chair of ICORN (Irish Hepatitis C Outcomes Research Network) and co-National Specialty Director, Infectious Diseases, Royal College of Physicians of Ireland.
I am the co-director of the Department of GU Medicine and Infectious Diseases Clinical Studies Unit, the department has an active national and international research reputation. I have secured funding from national and international funds including FP-7 funding in 2012. I have been and am the supervisor for a number of MD and PhD degrees covering research topics in medical education, cost effectiveness of medical care, molecular and clinical epidemiology, immunology of host response to infections, neurocognitive disease in HIV infection and innovative interventions to affect social behaviours in disease modelling. Present areas of research interest include immune biology of ageing and neurocognitive change in HIV infection; HPV vaccinology; HCV vaccine studies, HIV epidemiology, HCV therapeutics and HCV epidemiology,
I have published over 100 peer-reviewed articles, 3416 citations and h-index score is 23.
The department provides a rich environment and actively supports trainees to undertake designated research work. The department now hosts a research forum that meets monthly at which clinicians, trainees, scientists and other partners present current and planned research.
The HIV cohort is the largest patient cohort in Ireland, ~3000 HIV+ patients attend the department for care. Within this cohort supported by partnerships with immunologists in TCD and SJH and other clinicians and scientists there are multiple opportunities to explore HIV-related research themes. Historically areas have included cardiovascular disease, renal disease, vaccine immune responses, hepatitis C infection and pharmacokinetic studies of differing antiretroviral therapies. Present areas of active research have been described in the prior section. The department is supported by the appointment of Dr Jennifer Kieran who has a specific interest in pharmaco-ecconomics and has supported research projects in differing areas of care delivery.
Active research partners include Professor Joe Keane (TCD/SJH), Professor Rose Anne Kenny (TCD/SJH); Dr Paddy Mallon (UCD/MMUH); Professor Mary Horgan (UCC); Dr Catherine Fleming and Dr Helen Tuite (UCHG/UCG); Professor Suzanne Norris (TCD/SJH); Dr Colin Doherty (TCD/SJH); Professor Cliona O Farrelly (TCD); Professor Nigel Stephenson (TCD); Professor Clair Gardiner (TCD); Professor Orla Sheils (TCD); Professor Mark Little (TCD/AMNCH); Professor Lucy Dorrell (Oxford); Professor George Mellotte (TCD/AMNCH); Dr Cillian DeGascun (National Virus Reference Laboratory); Dr Kelly O'Brien (Toronto) and Professor Emma Stokes (TCD).
Within our general infectious diseases programme we have commenced a research programme in bone and joint disease (PhD candidate), in outcomes of complicated infections in diabetes and in antimicrobial stewardship initiatives (PhD candidate).
My role in the CRF affords our trainees the opportunity to access both the facility and the multidisciplinary team based therein.
Between 2012 and 2015 I was Dean of Postgraduate Training, RCPI and in that post partnered with Professor Mary Horgan, incoming President of RCPI and Dr Deirdre Bennett (PhD) - colleagues in UCC - to establish a research network exploring the determinants of outcomes to training at both PhD and MD level. The group was the recipient of the inaugural HRB MERG award.